Abstract | OBJECTIVE: MATERIALS AND METHODS: We obtained one ashwagandha product from India (liquid extract) and one product from US (Herb Pharma; liquid extract). We prepared two serum pool each for IL-6, C-reactive protein and digoxin by combining appropriate left-over specimens submitted to our hospital laboratory for such tests. Then aliquots of each pools were supplemented with 10, 25 or 50 µL of ashwagandha extract followed by re-analysis for appropriate analyte and comparing values with original pool. RESULTS: CONCLUSION:
|
Authors | Amitava Dasgupta, Tamal K Sengupta, Elaine M Trinh, Alejandra Russell |
Journal | Annals of clinical and laboratory science
(Ann Clin Lab Sci)
Vol. 52
Issue 2
Pg. 336-338
(Mar 2022)
ISSN: 1550-8080 [Electronic] United States |
PMID | 35414513
(Publication Type: Journal Article)
|
Copyright | © 2022 by the Association of Clinical Scientists, Inc. |
Chemical References |
- Interleukin-6
- Plant Extracts
- Digoxin
- C-Reactive Protein
- Ashwagandha
|
Topics |
- C-Reactive Protein
- COVID-19
- Digoxin
- Humans
- Immunoassay
- Interleukin-6
- Medicine, Ayurvedic
- Plant Extracts
(therapeutic use)
- Withania
|